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Abstract:  
Background: Despite the fact that reduction mammaplasty is an effective and efficient treatment to symptomatic 
macromastia, frequently, women demanding this treatment are accepted or not depending on body mass index criteria. 
The aim of this work was to compare changes of quality of life on obese and no-obese women who undergoing breast 
reduction mammaplasty.  
Methods: A prospective study was performed on 56 consecutive women undergoing bilateral reduction mammaplasty 
for symptomatic macromastia, 21 of them had a BMI lower than 30 (No-obese group) and 35 with 30 or higher BMI 
(Obese group). Short Form SF-36 quality of life questionnaires were answered at interviews a week before the surgery 
and six months after. To evaluate the change of quality of life we used “effect size”.  
Results: Preoperative SF36 scores did not make differences between both groups. Six months after surgery only 
postoperative physical score of no-obese patients was significantly higher than obese one (52.11 vs 48.47, p>0.05). Both 
groups increased clearly their quality of life showing an increment of all SF36 domains with an effect size ranged from 
0.53 to 2.07. More than seventy percent of obese women improved their scores exceeding means of preoperative 
scores.  
Conclusion: According to our results and the fact that the main goal of the breast reduction is ameliorate the quality of 
life there is no justification for exclusion obese patients with BMI >30 who suffer from symptomatic macromastia from 
reduction mammaplasty.  
Therapy: Level III of Evidence.  
Keywords: Reduction mammaplasty, Symptomatic macromastia, Obese, SF-36 health questionnaire, Effect size. 
1. INTRODUCTION 
Reduction mammaplasty (RM) and obesity is a fre- 
quent topic but most published articles are concerned 
with early surgical complications in those obese pati- 
ents who undergoing a RM for symptomatic macro- 
matia (SM) describing frequently an increment of the 
risks of complications in this group of patient. Although, 
some of them quantifying this risk stated that obesity 
status increases the odds ratio of experiencing compli- 
cation by 11.8-fold after adjusting for other variables [1]
 
or that a body mass index (BMI) greater than 35 is 
associated with a 2fold-higher risk of complication [2-5], 
the majority of complications are minor and they do not 
affect cosmetic and functional outcomes [6,7]. 
Other point related to obesity and RM is that despite 
the effectiveness of RM for the treatment of symptomatic 
macromastia showing a strong degree of scientific 
evidence [8]
 
such surgery is often considered cosmetic 
and is rationed. BMI is often used as a criterion of 
selection, for example, a survey of funding criteria for 
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RM conducted in United Kingdom over 303Trust in 
2007 revealed that 198 of 245 responded specified a 
maximum BMI (range 25 to 32) as exclusion [9]. 
Although some articles [10-14] comment that these 
patients improved significantly their quality of life after 
breast reduction with the same extent as do those who 
are at normal weight, there is a paucity of specifically 
designed studies for the particular purpose of evaluate 
the effect of RM on obese patient and to compare them 
with those caused on no-obese patients.  
2. PATIENTS AND METHODS 
A prospective study was performed on 56 women 
who underwent bilateral RM for SM by one surgeon at 
Valdecilla University Hospital (Santander, Spain) from 
March 2010 to March 2013. Preoperative data such as 
age, measurement for height, weight, sternal notch-to-
nipple distance, presence of morbidities such as arterial 
hypertension, diabetes, chronic respiratory disease, 
smoking habit were recorded during at an appointment 
a week before surgery. Weight and height were con- 
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The RM technique consisted of the wise keyhole 
pattern with two different pedicles for translation of the 
nipple areola complex (NAC) a superomedial an 
inferior one and a free nipple graft was used in three 
patients (mean of breast tissue removed was 2652 g 
deviation standard (DS) 605.5). The amount of breast 
tissue removed was obtained by weighing the fresh 
breast tissue on a digital scale in the operating theatre. 
The average time of surgery was 2.9, (DS) 0.47 hours. 
Early surgical complications which happened during 30 
days after surgery were gathered prospectively.  
Short Form SF-36 quality of life (Spanish version 
1.4, June 1999) [15] questionnaires were answered at 
interviews a week before the surgery and six months 
after surgery. The Short Form-36 Health Survey is a 
validated and widely used questionnaire to assess 
health-related quality of life. It contains 36 items build- 
ing eight health subscales (physical function and activi- 
ties, daily activities, emotional status, social activities, 
mental health, vitality and energy, pain and general 
health) and two summary scores, physical health and 
mental health. Higher scores represent better health. 
We used the physical and mental summary scores to 
demonstrate changes separately for physical and men- 
tal functions. 
To evaluate the changes after RM, “effect size” was 
calculated according to the method recommended by 
Hedges,LV [16]. It has been suggested that an effect 
size of 0.2 or less is small, 0.5 is moderate and 0.8 or 
greater is large [17]. 
We made comparison between two group of pati- 
ents, No-Obese (BMI >30 Kg/m2) and Obese (BMI 30 
Kg/m2). 
3. RESULTS 
Characteristic of the patients are described on Table 
1. Tables 2 and 3 show mean and SD of SF-36 scores 
of the both groups at week before and six months after 
surgery. Effect size as method to evaluate the effect- 
Table 1: Characteristic of 56 Patients with Symptomatic Macromastia who Undergoing Reduction Mammaplasty 
Group No Obese (n=21) Obese (n=35) p* 
Age (years) 38.9 (12) 42 (13.3) 0.370 
BMI (kg/m
2
) 27.6 (1.8) 34.2 (3.8) 0.001 
Total amount of breast tissue removed (g.) 1278.5 (588.9) 1654.2 (620.2) 0.023 
Smoker 45 % 41% 0.784 
Co-Morbidities 9.5 % 38.9% 0.015 
Early complications 19% 31.4% 0.311 
n = Number of patients; SD = Standard deviation; BMI = Body mass index.  
*Mann-Whitney and Chi-Square test, statistical significance p<0.05. 
 
Table 2: Short Form-36 Questionnaire Scores of Both Group of Patients a Week before Surgery 
No-Obese Obese) 
Dimension 
Mean SD Mean SD 
P* 
Physical function 73.5 17.72 61.8 26.04 0.129 
Role physical 41.6 40.56 56.6 42.77 0.247 
Bodily pain 33.3 17.53 38.2 24.01 0.350 
General health 62.2 18.28 59.8 20.24 0.671 
Vitality 46.4 17.47 48.8 17.54 0.327 
Social function 55.9 24.56 61.4 28.09 0.412 
Role emotional 49.2 45.48 57.8 43.16 0.500 
Mental health 49.7 18.65 59.0 22.61 0.110 
Physical component 42.9 6.59 40.7 8.88 0.310 
Mental component 36.0 11.60 42.0 13.58 0.131 
SD = standard deviation. 
*Mann-Whitney test, statistical significance p<0.05. 
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iveness of RM is demonstrated on Tables 4. Table 5 
shows differences of SF36 domains between preopera- 
tive and postoperative evaluations of both groups. 
4. DISCUSSION 
Although obese patients had a major proportion of 
comorbidities such as diabetes mellitus, arterial hyper- 
tension, asthma (31%) and the fact that the amount of 
breast tissue removed was higher than no-obese pati- 
ents with an average difference of 376 grams, so their 
breasts must have been quite larger, SF-36 domains 
scores did not make differences statistically significant 
between both groups. No-obese group scored a very 
low mental component 36.01. 
RM results in great relief of physical symptoms and 
pain increasing physical and body pain scores dramati- 
cally with an amazing effect sizes on no-obese patients 
(1.26 and 2.07). As a result, by alleviating the physical 
complaints caused by heavy breasts, this surgical 
Table 3: Short Form-36 Questionnaire Scores of both Groups of Patients Six Months after Breast Reduction Surgery 
No-Obese Obese) 
Dimension 
Mean SD Mean SD 
P* 
Physical function 91.7 13.80 84.7 18.45 0.108 
Role physical 88.2 29.47 77.9 36.99 0.364 
Bodily pain 77.7 24.59 67.7 21.73 0.107 
General health 78.4 18.28 72.7 21.68 0.299 
Vitality 68.2 17.61 70.8 17.81 0.626 
Social function 90.4 15.00 83.0 24.27 0.435 
Role emotional 92.1 18.74 87.0 30.64 0.947 
Mental health 75.1 15.64 74.6 22.58 0.697 
Physical component 52.1 7.42 48.4 6.73 0.020 
Mental component 50.2 7.35 50.0 10.99 0.518 
SD = standard deviation. 
*Mann-Whitney test, statistical significance p<0.05. 
 
Table 4: Effect Sizes on Both Groups of Patients after Breast Reduction Calculated using Hedges Method. P Adjusted 
or Proportion of Patients who Scored after Surgery a Higher Score than the Mean Preoperative One on 
Respective Domains 
Effect Size P Ajusted 
SF36 Scores 
No Obese Obese No Obese Obese 
Physical function 1.11 0.99 0.87 0.84 
Role physical 1.26 0.53 0.90 0.70 
Bodily pain 2.07 1.27 0.98 0.90 
General health 0.87 0.61 0.81 0.73 
Vitality 1.22 1.23 0.89 0.89 
Social function 1.62 0.81 0.95 0.79 
Role emotional 1.16 0.77 0.88 0.78 
Mental health 1.43 0.68 0.92 0.75 
Physical component 1.28 0.97 0.90 0.83 
Mental component 1.39 0.64 0.92 0.74 
Effect Size (Cohen’s d, r) & Standard Deviation  
Effect size is a standard measure that can be calculated from any number of statistical outputs.  
One type of effect size, the standardized mean effect, expresses the mean difference between two groups in standard deviation units. Typically, you’ll see this 
reported as Cohen’s d, or simply referred to as “d.” Though the values calculated for effect size are generally low, they share the same range as standard deviation 
(-3.0 to 3.0), so can be quite large. Interpretation depends on the research question. The meaning of effect size varies by context, but the standard interpretation 
offered by Cohen (1988) is: .8 = large (8/10 of a standard deviation unit); .5 = moderate (1/2 of a standard deviation); .2 = small (1/5 of a standard deviation. 
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treatment gives an excellent improvement in quality of 
life and physical appearance (Figures 1 and 2).  
Table 5: Comparison Between Both Groups. SF36 
Score Differences Between Preoperatively and 
Postoperative Evaluations 
Dimension No Obese Obese p 
Physical function 18.79 23.58 0.719 
Role physical 51.56 19.72 0.062 
Bodily pain 48.25 27.46 0.071 
General health 11.48 10.74 0.877 
Vitality 21.11 18.27 0.578 
Social function 34.37 18.54 0.084 
Role emotional 45.83 19.64 0.106 
Mental health 22.83 11.67 0.123 
Physical component 10.57 7.77 0.605 
Mental component 14.29 5.50 0.049 
*Mann-Whitney test, statistical significance p<0.05. 
 
 
Figure 1: Schematic representation of physical and mental 
component scores of SF-36 questionnaires of both groups.  
The size effects, which demonstrate the effective- 
ness of RM, were higher in no-obese patients ranged 
from 0.87 to 2.07; even though, changes in obese 
patients were relevant ranged from 0.53 to 1.27 and in 
all domains more than 70 percent of obese women 
improved their scores exceeded means of preoperative 
ones. 
Comparison of preoperative and postoperative 
scores indicates that there was a significant improve- 
ment in health-related quality of life at six months after 
RM showing the effectiveness of this surgical treat- 
ment. Both groups improved their quality scores after 
surgery and only physical component of obese patients 
scored significantly lower comparing both groups. 
 
Figure 2: Change of appearance after breast reduction. 
In our study, obese patients, who have a BMI over 
30, suffering macromastia benefited clearly from RM, 
which made a normalizing effect on the quality of life 
evaluated by Short Form SF-36 showing a defined 
improvement on all SF36 domains. These findings are 
similar to what have been published by Singh [8], 
Blomqvist L [14] and Saariniemi K [18] in patients with 
SM with less BMI. The improvement in health-related 
quality of life experienced by obese women with macro- 
mastia who underwent RM was mainly based on the 
improvement of physical health with a size effect of 
0.97 (which is considered so large).  
5. CONCLUSION 
In summary, according to our findings obese pati- 
ents with symptomatic breast hipertrophy are clearly 
positive affected by RM increasing their quality of life 
with a large size effects. Thinking that the amelioration 
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of quality of life is the main goal of this type of surgery 
there are not scientific reasons to exclude these 
patients from this surgical treatment based on BMI 
index by contrast there is enough justification for 
questioning BMI as selection criteria.  
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